DarioHealth (DRIO) Misses Q1 EPS by 1c, Beats on Revenues

DarioHealth (NASDAQ: DRIO) reported Q1 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $1.76 million versus the consensus estimate of $1.74 million.

For earnings history and earnings-related data on DarioHealth (DRIO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c